In The News

You are here

Dr. Theodore Schwartz Awarded NIH Grant for Epilepsy Laser Treatment Research

Neurosurgeon Dr. Theodore Schwartz, along with Dr. Chris Schaffer of Biomedical Engineering at Cornell University in Ithaca, has received a prestigious 2-year NIH grant to lead research on ground-breaking laser treatments for epilepsy. In his lab at the Weill Cornell Brain and Spine Center, Dr. Schwartz will use a femtosecond laser on animal models to make microscopic incisions in portions of the brain in hopes to prevent epileptic seizures yet preserve function.

Pediatric Epilepsy Team Featured in Daily News

Dr. Theodore Schwartz, Dr. Jeffrey Greenfield, and Dr. Juliann Paolicchi were all featured in the New York Daily News on October 7, 2012. The article told the dramatic story of simultaneous surgeries — on a 12-year-old girl, whose procedure provided relief from epileptic seizures; and on her father, whose heart attack at his daughter's bedside required a lifesaving stent to open a blocked artery.

Dr. Mark Souweidane Brings His Expertise to Germany to Teach Advanced Endoscopic Neurosurgery

Dr. Mark Souweidane will co-lead a three-day endoscopic neurosurgery course this spring in Germany with Dr. Peter Nakaji of Barrow Neurological Associates. The course will offer a comprehensive overview on endoscopic techniques in intracranial neurosurgery, including didactic lectures, illustrative cases, and cadaveric workshop sessions. Procedures will include managing complex hydrocephalus, removing intraventricular tumors, and endoscopic transnasal approaches to the pituitary fossa and the entire midline skull base.

Dr. Stieg Helps Cut the Ribbon on New Regenerative Medicine Laboratories at Burke

The mission of the new Regenerative Medicine Laboratories is to advance the science of neurological disorders and trauma and reduce disability from stroke, brain and spine injury, multiple sclerosis, Alzheimer's and Parkinson's diseases, and other conditions affecting the brain and spine.

Clinical Trial Tests New Approach to Idiopathic Intracranial Hypertension (Pseudotumor Cerebri)

Dr. Athos Patsalides and Dr. Marc Dinkin are now enrolling patients in a FDA-approved research study for idiopathic intracranial hypertension (IIH), also known as pseudotumor cerebri. This innovative new trial is testing the effectiveness of stent placement in patients with severe intracranial hypertension who have not responded to other treatments.

Pages